Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.

Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, Van Bockstal M, Van Dorpe J, De Neve W, Denys H, Vandecasteele K.

BMC Cancer. 2018 Nov 12;18(1):1101. doi: 10.1186/s12885-018-5007-0.

2.

EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.

Vandecasteele K, Tummers P, Van Bockstal M, De Visschere P, Vercauteren T, De Gersem W, Denys H, Naert E, Makar A, De Neve W.

BMC Cancer. 2018 Sep 17;18(1):898. doi: 10.1186/s12885-018-4800-0.

3.

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.

Van Bockstal M, Baldewijns M, Colpaert C, Dano H, Floris G, Galant C, Lambein K, Peeters D, Van Renterghem S, Van Rompuy AS, Verbeke S, Verschuere S, Van Dorpe J.

Histopathology. 2018 Aug 30. doi: 10.1111/his.13741. [Epub ahead of print]

PMID:
30168167
4.

Collagen Alignment and Recurrence of DCIS-Letter.

Libbrecht L, Lambein K, Van Bockstal M, Denys H.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):613. doi: 10.1158/1055-9965.EPI-17-1071. No abstract available.

PMID:
29716929
5.

Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in schwannomas: the chosen clone matters.

Creytens D, Van Bockstal M, Ferdinande L, Van Dorpe J.

Hum Pathol. 2018 Jun;76:167-168. doi: 10.1016/j.humpath.2018.02.026. Epub 2018 Apr 7. No abstract available.

PMID:
29634981
6.

Routine histopathological examination after female-to-male gender-confirming mastectomy.

Van Renterghem SMJ, Van Dorpe J, Monstrey SJ, Defreyne J, Claes KEY, Praet M, Verbeke SLJ, T'Sjoen GGR, Van Bockstal MR.

Br J Surg. 2018 Jun;105(7):885-892. doi: 10.1002/bjs.10794. Epub 2018 Apr 5.

PMID:
29623678
7.

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits.

Van Heetvelde M, Van Bockstal M, Poppe B, Lambein K, Rosseel T, Atanesyan L, Deforce D, Van Den Berghe I, De Leeneer K, Van Dorpe J, Vral A, Claes KBM.

Cancer Lett. 2018 Jul 1;425:125-133. doi: 10.1016/j.canlet.2018.03.026. Epub 2018 Mar 23.

PMID:
29580810
8.

A Rare Mammary Serendipity: Mucinous Metaplasia of the Breast.

Van Bockstal M.

Int J Surg Pathol. 2018 Dec;26(8):730. doi: 10.1177/1066896918761809. Epub 2018 Mar 13. No abstract available.

PMID:
29532695
9.

Some diffuse large B cell lymphomas (DLBCLs) present with clone-dependent TTF-1 positivity.

Van Bockstal M, Camboni A, De Vlieghere E, De Ryck F, Candaele AS, Geenen S, Vandemaele L, De Wever O, Libbrecht L, Verbeke S, Van Dorpe JA.

Histopathology. 2018 Jun;72(7):1228-1230. doi: 10.1111/his.13477. Epub 2018 Mar 25. No abstract available.

PMID:
29393528
10.

A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer.

Van Bockstal M, Floris G, Galant C, Lambein K, Libbrecht L.

Breast. 2018 Feb;37:52-55. doi: 10.1016/j.breast.2017.10.012. Epub 2017 Oct 31. Review.

PMID:
29100044
11.

Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA.

Verbeke R, Lentacker I, Wayteck L, Breckpot K, Van Bockstal M, Descamps B, Vanhove C, De Smedt SC, Dewitte H.

J Control Release. 2017 Nov 28;266:287-300. doi: 10.1016/j.jconrel.2017.09.041. Epub 2017 Oct 5.

PMID:
28987878
12.

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma?

Van Bockstal M, Libbrecht L, Floris G, Lambein K, Pinder S.

Ann Oncol. 2017 Sep 1;28(9):2317. doi: 10.1093/annonc/mdx253. No abstract available.

PMID:
28911076
13.

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Lambein K, Van Bockstal M, Vandemaele L, Van den Broecke R, Cocquyt V, Geenen S, Denys H, Libbrecht L.

Virchows Arch. 2017 Nov;471(5):575-587. doi: 10.1007/s00428-017-2161-8. Epub 2017 May 31.

PMID:
28567637
14.

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth.

Lapeire L, Hendrix A, Lecoutere E, Van Bockstal M, Vandesompele J, Maynard D, Braems G, Van Den Broecke R, Müller C, Bracke M, Cocquyt V, Denys H, De Wever O.

Oncotarget. 2017 Jul 18;8(29):47239-47249. doi: 10.18632/oncotarget.17592.

15.

Whipple's disease in granulomatous disguise: a challenging diagnosis with many histopathological pitfalls.

Van Bockstal M, Hoorens A, Van den Bosch F, Creytens D, Verbeke S, Van Dorpe J.

Virchows Arch. 2017 Apr;470(4):465-468. doi: 10.1007/s00428-017-2084-4. Epub 2017 Feb 6. No abstract available.

PMID:
28168330
16.

Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization.

De Clercq K, Schelfhout C, Bracke M, De Wever O, Van Bockstal M, Ceelen W, Remon JP, Vervaet C.

Biomaterials. 2016 Jul;96:33-46. doi: 10.1016/j.biomaterials.2016.04.012. Epub 2016 Apr 22.

PMID:
27135715
17.

The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.

Van Bockstal M, Libbrecht L, Floris G, Lambein K.

Histopathology. 2016 Sep;69(3):522-3. doi: 10.1111/his.12977. Epub 2016 May 5. No abstract available.

PMID:
27028714
18.

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma.

Leonard B, Starrett GJ, Maurer MJ, Oberg AL, Van Bockstal M, Van Dorpe J, De Wever O, Helleman J, Sieuwerts AM, Berns EM, Martens JW, Anderson BD, Brown WL, Kalli KR, Kaufmann SH, Harris RS.

Clin Cancer Res. 2016 Sep 15;22(18):4746-55. doi: 10.1158/1078-0432.CCR-15-2910. Epub 2016 Mar 25.

19.

Simultaneous Parenchyma-Preserving Liver Resection, Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stage IV Colorectal Cancer.

Abreu de Carvalho LF, Scuderi V, Maes H, Cupo P, Geerts B, Van Bockstal M, Gremonprez F, Willaert W, Pattyn P, Troisi R, Ceelen W.

Acta Chir Belg. 2015 Jul-Aug;115(4):261-7. Erratum in: Acta Chir Belg. 2015 Jan;115(5):385.

PMID:
26324026
20.

Fibroblast-induced matrix remodeling paves the path for invasion.

Van Bockstal M, Libbrecht L, De Wever O.

Cell Cycle. 2015;14(6):793-4. doi: 10.1080/15384101.2015.1010968. No abstract available.

21.

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.

Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, Van den Broecke R, Cocquyt V, Denys H, Bracke M, Libbrecht L, De Wever O.

Oncoscience. 2014 Oct 15;1(10):634-48. eCollection 2014.

22.

Simultaneous Parenchyma-Preserving Liver Resection, Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stage IV Colorectal Cancer.

Carvalho LF, Scuderi V, Maes H, Cupo P, Geerts B, Van Bockstal M, Gremonprez F, Willaert W, Pattvn P, Troisi R, Ceelen W.

Acta Chir Belg. 2015 Jan;115(5):385. doi: 10.1080/00015458.2015.11681136. No abstract available.

PMID:
27421666
23.

Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P, Vandesompele J, Vanhove C, Maynard D, Lehuédé C, Muller C, Valet P, Gespach CP, Bracke M, Cocquyt V, Denys H, De Wever O.

Cancer Res. 2014 Dec 1;74(23):6806-19. doi: 10.1158/0008-5472.CAN-14-0160. Epub 2014 Sep 24.

24.

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

Van Bockstal M, Lambein K, Denys H, Braems G, Nuyts A, Van den Broecke R, Cocquyt V, De Wever O, Libbrecht L.

Virchows Arch. 2014 Sep;465(3):275-89. doi: 10.1007/s00428-014-1609-3. Epub 2014 Jun 29.

PMID:
24973889
25.

2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.

Lambein K, Van Bockstal M, Denys H, Libbrecht L.

J Clin Oncol. 2014 Jun 10;32(17):1856-7. doi: 10.1200/JCO.2013.54.2530. Epub 2014 Apr 28. No abstract available.

PMID:
24778399
26.

Hemangiomatosis of the spleen in a patient with Klippel-trénaunay syndrome.

Dekeyzer S, Houthoofd B, De Potter A, Van Bockstal M, Smeets P, Vogelaers D.

JBR-BTR. 2013 Nov-Dec;96(6):357-9.

PMID:
24617177
27.

Carcinoma-associated fibroblasts provide operational flexibility in metastasis.

De Wever O, Van Bockstal M, Mareel M, Hendrix A, Bracke M.

Semin Cancer Biol. 2014 Apr;25:33-46. doi: 10.1016/j.semcancer.2013.12.009. Epub 2014 Jan 7. Review.

PMID:
24406210
28.

Distinguishing score 0 from score 1+ in HER2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance.

Lambein K, Van Bockstal M, Vandemaele L, Geenen S, Rottiers I, Nuyts A, Matthys B, Praet M, Denys H, Libbrecht L.

Am J Clin Pathol. 2013 Oct;140(4):561-6. doi: 10.1309/AJCP4A7KTAYHZSOE.

PMID:
24045554
29.

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.

Van Bockstal M, Lambein K, Gevaert O, De Wever O, Praet M, Cocquyt V, Van den Broecke R, Braems G, Denys H, Libbrecht L.

Histopathology. 2013 Oct;63(4):520-33. doi: 10.1111/his.12188. Epub 2013 Jul 26.

PMID:
23889174
30.

Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression.

De Boeck A, Hendrix A, Maynard D, Van Bockstal M, Daniëls A, Pauwels P, Gespach C, Bracke M, De Wever O.

Proteomics. 2013 Jan;13(2):379-88. doi: 10.1002/pmic.201200179. Epub 2013 Jan 6.

PMID:
23175172
31.

Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model.

Sys G, Van Bockstal M, Forsyth R, Balke M, Poffyn B, Uyttendaele D, Bracke M, De Wever O.

Cancer Lett. 2012 Dec 29;326(1):69-78. doi: 10.1016/j.canlet.2012.07.023. Epub 2012 Jul 24.

PMID:
22841668
32.

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.

De Leeneer K, Van Bockstal M, De Brouwer S, Swietek N, Schietecatte P, Sabbaghian N, Van den Ende J, Willocx S, Storm K, Blaumeiser B, Van Asperen CJ, Wijnen JT, Leunen K, Legius E, Michils G, Matthijs G, Blok MJ, Gomez-Garcia E, De Paepe A, Tischkowitz M, Poppe B, Claes K.

Breast Cancer Res Treat. 2012 May;133(1):393-8. doi: 10.1007/s10549-012-1998-4. Epub 2012 Feb 28.

PMID:
22370629
33.

Glypican-3 is a marker for solid pseudopapillary neoplasm of the pancreas.

Hav M, De Potter A, Ferdinande L, Van Bockstal M, Lem D, Eav S, Pattyn P, Praet M, Cuvelier C, Libbrecht L.

Histopathology. 2011 Dec;59(6):1278-9. doi: 10.1111/j.1365-2559.2011.03998.x. Epub 2011 Oct 25. No abstract available.

PMID:
22026458
34.

Malignant peritoneal mesothelioma in a patient with Li-Fraumeni syndrome.

Ceelen WP, Van Dalen T, Van Bockstal M, Libbrecht L, Sijmons RH.

J Clin Oncol. 2011 Jun 10;29(17):e503-5. doi: 10.1200/JCO.2010.34.1933. Epub 2011 Apr 4. No abstract available.

PMID:
21464421

Supplemental Content

Loading ...
Support Center